In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Selected Start-Ups (09/2009)

Executive Summary

In Vivo briefly describes these recently founded companies: Acetylon Pharmaceuticals, Avineuro Pharmaceuticals, Nanovis, TargAnox, TheraCell and Treventis.

You may also be interested in...



Biocon Stelara Settlement Places Firm Among Earlier US Rivals

Biocon Biologics has secured a launch date for its planned US biosimilar to Stelara that puts it ahead of some of the competition.

Executives On The Move: Joseph Papa Joins Emergent BioSolutions As CEO Among Other Industry Moves

Recent moves within the industry include changes at the top for Ocular Therapeutix and Rayzebio, plus a new CEO for Bellicum Pharmaceuticals.

AI Clinical Summarization Tools Sit In 'Regulatory Grey Area', Experts Warn

The EU lacks concrete guidance on whether clinical summarization large language models are considered medical devices. Experts push for EU adoption of the FDA “non-device” category.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV003365

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel